Viking Global Equities II LP

10% owner at Sio Gene Therapies Inc. · on record since Jul 13, 2016
10% owner at APi Group Corp · on record since Mar 7, 2024
10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
10% owner at Wayfair Inc. · on record since Oct 6, 2014
10% owner at FIRST DATA CORP · on record since Oct 15, 2015
Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
10% owner at Steel Excel Inc. · on record since Jun 26, 2019
Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019
10% owner at Roivant Sciences Ltd. · on record since Oct 1, 2021
10% owner at ADVANCED PHOTONIX INC · on record since Jan 5, 2022
Former 10% Owner at Sio Gene Therapies Inc. · on record since Jul 12, 2019

Insider trading activity of Viking Global Equities II LP

Transactions on record: 12; since Feb 8, 2016

Open-market buys: 8; $25M

Open-market sells: 0

Companies traded: 2; last filing Jun 7, 2018

Figures computed from official regulatory filings — .

Companies where Viking Global Equities II LP has traded

1 tx · $25M · Jun 7, 2018
11 tx · Feb 8, 2016

Track record of Viking Global Equities II LP

Open-market buys: 8

Last buy: Jun 5, 2018

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of Viking Global Equities II LP

Co-insiders of Viking Global Equities II LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Sio Gene Therapies Inc.Listing unverified	Jun 7, 2018	Buy	14,285,714	1.75 USD	$25M	conv 55ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	15,072	—	n/a (No price was disclosed in the filing)	conv 61ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	OtherD (derivative)	-4,444,444	—	n/a (No price was disclosed in the filing)		SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	481,567	—	n/a (No price was disclosed in the filing)	conv 61ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	OtherD (derivative)	-4,444,444	—	n/a (No price was disclosed in the filing)		SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Other	1,709,401	—	n/a (No price was disclosed in the filing)		SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	20,407	—	n/a (No price was disclosed in the filing)	conv 41ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Other	1,709,401	—	n/a (No price was disclosed in the filing)		SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	1,000,000	—	n/a (No price was disclosed in the filing)	conv 63ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	256,986	—	n/a (No price was disclosed in the filing)	conv 61ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	261,447	—	n/a (No price was disclosed in the filing)	conv 61ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	5,335	—	n/a (No price was disclosed in the filing)	conv 42ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Sio Gene Therapies Inc.Listing unverified	Jun 7, 2018	Buy	14,285,714	1.75 USD	$25M	conv 55ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	15,072	—	n/a (No price was disclosed in the filing)	conv 61ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	OtherD (derivative)	-4,444,444	—	n/a (No price was disclosed in the filing)		SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	481,567	—	n/a (No price was disclosed in the filing)	conv 61ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	OtherD (derivative)	-4,444,444	—	n/a (No price was disclosed in the filing)		SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Other	1,709,401	—	n/a (No price was disclosed in the filing)		SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	20,407	—	n/a (No price was disclosed in the filing)	conv 41ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Other	1,709,401	—	n/a (No price was disclosed in the filing)		SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	1,000,000	—	n/a (No price was disclosed in the filing)	conv 63ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	256,986	—	n/a (No price was disclosed in the filing)	conv 61ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	261,447	—	n/a (No price was disclosed in the filing)	conv 61ClusterFirst in 12mo	SEC
Editas Medicine, Inc.Listing on record	Feb 8, 2016	Buy	5,335	—	n/a (No price was disclosed in the filing)	conv 42ClusterFirst in 12mo	SEC